CDSCO · Draft notification
India proposes CCTV surveillance at drug sales premises
Official source date: · Source checked
CDSCO lists G.S.R. 791(E), a proposed amendment to the Drugs Rules, 1945 concerning mandatory CCTV installation at sales premises.
Who should review this?
Drug wholesalers, retailers and teams responsible for licensed sales premises in India.
What it means for pharmaceutical teams
The announcement concerns sales premises. The listing alone should not be read as a new manufacturing GMP obligation. A draft proposal and an enacted amendment have different practical consequences.
Practical review checklist
PharmaEdges reading prompts for your own applicability review:
- Locate G.S.R. 791(E) in the official Gazette listing.
- Read the proposed scope, conditions and consultation provisions in the full document.
- Check for a final notification before making a compliance decision or setting an implementation deadline.
Official source and verification
Read the CDSCO source (opens in a new tab)
This article summarises the linked official material. The context and checklist are PharmaEdges explanatory commentary, not additional regulatory requirements. The source publication date is separate from this article’s publication date.
For a correction, contact PharmaEdges with the article URL and supporting source. Read our news publishing policy.
Related regulatory news
- EMA announces permanent clinical-trial application advice from January 2027
- EMA publishes year-end 2026 advice for type I variation submissions
- EMA reports on international API inspection cooperation
- India proposes extending prior intimation for certain BA/BE studies